January 10, 2010
The U.S. Department of Agriculture (USDA) granted Merial Limited full licensure for a canine melanoma vaccine, a therapeutic DNA vaccine designed to aid in extending survival of dogs with oral melanoma. Merial plans to launch the product at the North American Veterinary Conference Jan. 16 - 20.
Melanoma is a common type of cancer in dogs and is the most common malignant tumor of the dog's mouth and can also occur in the nail and footpad. Canine oral melanoma may affect any breed and is a highly aggressive cancer. Normal treatment for canine oral melanoma includes surgery and/or radiation, but even after successful local treatment, the melanoma frequently spreads throughout the body, including the lymph nodes, liver, lungs and kidneys, and is often resistant to chemotherapy.
Merial is a licensee of Vical Incorporated. www.merial.com